Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019 | ||
By: GlobeNewswire - 19 Feb 2020 | Back to overview list |
|
PORTLAND, Maine, Feb. 19, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a correction to its unaudited loss per share calculation for the fourth quarter ended December 31, 2019. The unaudited weighted average shares outstanding was incorrectly reported as 5,408,000 resulting in a loss per share calculation of ($0.06). The corrected unaudited weighted average shares outstanding is 7,210,000 resulting in a loss per share calculation of ($0.04).
Conference Call: About ImmuCell: Contact: Michael F. Brigham, President and CEO Joe Diaz, Robert Blum and Joe Dorame |
||
|
||
Copyright 2020 GlobeNewswire | Back to overview list |